168 HR buprenorphine 0.0075 MG/HR Transdermal System

RxCUI
1542997
RxNorm name
168 HR buprenorphine 0.0075 MG/HR Transdermal System
Display name
Buprenorphine (Transdermal)
Full name
168 HR buprenorphine 0.0075 MG/HR Transdermal System
Term type
SCD
Status
Active
Strength
7.5 mcg/hr
Dose form
168 HR Patch
Route
Transdermal
Updated
2026-11-19 15:42:26

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082014
Active start
082014
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
buprenorphine0.0075 MG / 1 HRbuprenorphinebuprenorphine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Transdermal System316987

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
buprenorphine1819

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0093-3239-400093-3239Buprenorphine BuprenorphineTeva Pharmaceuticals USA, Inc.ANDA204937
3215-1522-043215-1522Buprenorphine BuprenorphineAveva Drug Delivery Systems Inc.ANDA210272
42858-353-4042858-353Buprenorphine BuprenorphineRhodes Pharmaceuticals LLCNDA021306
50742-373-0450742-373Buprenorphine BuprenorphineINGENUS PHARMACEUTICALS, LLCANDA210272
69238-1505-269238-1505Buprenorphine BuprenorphineAmneal Pharmaceuticals NY LLCANDA211586

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2049370093-3239Buprenorphine BuprenorphineANDATeva Pharmaceuticals USA, Inc.
ANDA2102723215-1522Buprenorphine BuprenorphineANDAAveva Drug Delivery Systems Inc.
NDA02130642858-353Buprenorphine BuprenorphineNDA AUTHORIZED GENERICRhodes Pharmaceuticals LLC
ANDA21158669238-1505Buprenorphine BuprenorphineANDAAmneal Pharmaceuticals NY LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 9 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00093323921rxnav_ndcsyes
00093323940rxnav_ndcsyes
03215152204rxnav_ndcsyes
42858035340rxnav_ndcsyes
50742037301rxnav_ndcsyes
50742037304rxnav_ndcsyes
60505707605rxnav_ndcsyes
69238150502rxnav_ndcsyes
59368041401rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BuprenorphineBUPRENORPHINERhodes Pharmaceuticals LLC2738feae-316e-426f-971c-5f142ac01b602026-05-29Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 42858-353-40
ndc (product): 42858-353
ndc11 (package): 42858035340
rxcui: 1542997
BuprenorphineBUPRENORPHINETeva Pharmaceuticals USA, Inc.36995ce3-b515-447b-baa9-aa14f84060d82026-05-12Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 0093-3239-40
ndc (product): 0093-3239
ndc11 (package): 00093323940
rxcui: 1542997
ButransBUPRENORPHINEKnoa Pharma LLC794aa355-66de-41b8-aedf-f2c40f6bc6642026-05-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1542997
BuprenorphineBUPRENORPHINEINGENUS PHARMACEUTICALS, LLC186e3be6-8bc0-4bb9-96f5-429d53632f452026-04-28Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 50742-373-04
ndc (product): 50742-373
ndc11 (package): 50742037304
rxcui: 1542997
BuprenorphineBUPRENORPHINEAveva Drug Delivery Systems Inc.1aae9b13-7431-42ef-8558-14a2325820e62026-04-28Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 3215-1522-04
ndc (product): 3215-1522
ndc11 (package): 03215152204
rxcui: 1542997
BuprenorphineBUPRENORPHINEAmneal Pharmaceuticals NY LLCc7d079fb-507f-436f-b794-2171b7d970672026-01-09Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 69238-1505-2
ndc (product): 69238-1505
ndc11 (package): 69238150502
rxcui: 1542997

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
794aa355-66de-41b8-aedf-f2c40f6bc664buprenorphine 7.5 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.0075 MG/HR Transdermal System [SCD] · buprenorphine 7.5 MCG/HR 7 Day Transdermal Patch [SY] · buprenorphine 7.5 MCG/HR 7 Day Transdermal System [SY]432These highlights do not include all the information needed to use BUTRANS ® safely and effectively. See full prescribing information for BUTRANS. BUTRANS ® (buprenorphine) transdermal system, CIII Initial U.S. Approval: 198120260501
36995ce3-b515-447b-baa9-aa14f84060d8buprenorphine 7.5 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.0075 MG/HR Transdermal System [SCD] · buprenorphine 7.5 MCG/HR 7 Day Transdermal Patch [SY] · buprenorphine 7.5 MCG/HR 7 Day Transdermal System [SY]420These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 198120240531
c7d079fb-507f-436f-b794-2171b7d97067buprenorphine 7.5 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.0075 MG/HR Transdermal System [SCD] · buprenorphine 7.5 MCG/HR 7 Day Transdermal Patch [SY] · buprenorphine 7.5 MCG/HR 7 Day Transdermal System [SY]419These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 198120260109
2738feae-316e-426f-971c-5f142ac01b60buprenorphine 7.5 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.0075 MG/HR Transdermal System [SCD] · buprenorphine 7.5 MCG/HR 7 Day Transdermal Patch [SY] · buprenorphine 7.5 MCG/HR 7 Day Transdermal System [SY]417These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System, CIII Initial U.S. Approval: 198120260529
186e3be6-8bc0-4bb9-96f5-429d53632f45buprenorphine 7.5 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.0075 MG/HR Transdermal System [SCD] · buprenorphine 7.5 MCG/HR 7 Day Transdermal Patch [SY] · buprenorphine 7.5 MCG/HR 7 Day Transdermal System [SY]44These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 198120260428
1aae9b13-7431-42ef-8558-14a2325820e6buprenorphine 7.5 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.0075 MG/HR Transdermal System [SCD] · buprenorphine 7.5 MCG/HR 7 Day Transdermal Patch [SY] · buprenorphine 7.5 MCG/HR 7 Day Transdermal System [SY]43These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 198120260428

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
2738feae-316e-426f-971c-5f142ac01b60These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System, CIII Initial U.S. Approval: 1981Rhodes Pharmaceuticals LLC | LTS Lohmann Therapy Systems Corp. | LTS Lohmann Therapie-Systeme AG20260529
2738feae-316e-426f-971c-5f142ac01b60These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System, CIII Initial U.S. Approval: 1981Rhodes Pharmaceuticals LLC | LTS Lohmann Therapy Systems Corp. | LTS Lohmann Therapie-Systeme AG20260526
36995ce3-b515-447b-baa9-aa14f84060d8These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981Teva Pharmaceuticals USA, Inc.20260512
186e3be6-8bc0-4bb9-96f5-429d53632f45These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981INGENUS PHARMACEUTICALS, LLC | DifGen Pharmaceuticals LLC | Aveva Drug Delivery Systems Inc.20260428
1aae9b13-7431-42ef-8558-14a2325820e6These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981Aveva Drug Delivery Systems Inc. | DifGen Pharmaceuticals LLC20260428
186e3be6-8bc0-4bb9-96f5-429d53632f45These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981INGENUS PHARMACEUTICALS, LLC | DifGen Pharmaceuticals LLC | Aveva Drug Delivery Systems Inc.20260323
2738feae-316e-426f-971c-5f142ac01b60These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System, CIII Initial U.S. Approval: 1981Rhodes Pharmaceuticals L.P. | LTS Lohmann Therapy Systems Corp. | LTS Lohmann Therapie-Systeme AG20260203
c7d079fb-507f-436f-b794-2171b7d97067These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981Amneal Pharmaceuticals NY LLC20260109
36995ce3-b515-447b-baa9-aa14f84060d8These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981Teva Pharmaceuticals USA, Inc.20240531
17ad1a5b-e89f-d5a3-d15b-2eb48bcded7dThese highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: 1981Apotex Corp. | Aveva Drug Delivery Systems Inc.20230706
37ca3288-80e0-5b4e-e063-6394a90a2498BUPRENORPHINE transdermal system, CIIIPraxis, LLC20230101

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN07BCDrugs used in opioid dependenceATC1-4buprenorphine
ATCN02AEOripavine derivativesATC1-4buprenorphine
FDASPLN0000175689Partial Opioid AgonistEPChas_epcbuprenorphine
FDASPLN0000175685Partial Opioid AgonistsMOAhas_moabuprenorphine
MEDRTD002047BuprenorphineCHEMhas_ingredientbuprenorphine
MEDRTD004342Drug HypersensitivityDISEASEci_withbuprenorphine
MEDRTD006556Heroin DependenceDISEASEmay_treatbuprenorphine
MEDRTD010146PainDISEASEmay_treatbuprenorphine
MEDRTN0000000154Opioid AntagonistsMOAhas_moabuprenorphine
MEDRTN0000175685Partial Opioid AgonistsMOAhas_moabuprenorphine
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pebuprenorphine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.0075 MG/HR
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY168 HR
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE3
CODESANDAANDA204937
CODESANDAANDA210272
CODESANDAANDA211586
CODESVUID4033704
NAMESPrescribable Synonymbuprenorphine 7.5 MCG/HR 7 Day Transdermal System
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File